Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4506 On Other Exchanges
Symbol
Exchange
4506 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Chiang J. Li M.D., FACP.

Head of Global Oncology, Executive Officer, Chief Executive Officer of Boston Biomedical, Inc, President of Boston Biomedical, Inc and Chief Medical Officer of Boston Biomedical, Inc,Sumitomo Dainippon Pharma Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 6 different industries.

See Board Relationships
50--

Background*

Dr. Chiang J. Li, M.D., FACP. serves as the President, Chief Executive Officer and Chief Medical Officer at Boston Biomedical, Inc. (BBI). Dr. Li serves as an Executive Officer and Head of Global Oncology of Sumitomo Dainippon Pharma Co., Ltd. He is the Founder of Cequent Pharmaceuticals, Inc. He serves as Head of Global Oncology at the DSP Group. Dr. Li served as the Chief Scientific Officer at Boston Biomedical, Inc. which he founded it in November 2006. He Founded ...

Read Full Background

Corporate Headquarters*

6-8 Doshomachi 2-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6203 5321
Fax: 81 6 6202 6028

Board Members Memberships*

Founder, Chairman of the Scientific Advisory Board and Director

Education*

MD
Harvard Medical School
Unknown/Other Education
Harvard-MIT Division of Health Sciences and Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4506:JP ¥1,306.00 JPY -4.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey J. Clarke Chief Executive Officer and Director
Eastman Kodak Co.
$758.9K
William S. Marth Chief Executive Officer, President and Director
Albany Molecular Research Inc.
$982.5K
Shigetaka Komori Chairman, Chief Executive Officer, Chairman of Compliance Committee and Chairman of Risk Management Committee
FUJIFILM Holdings Corporation
¥201.0M
Dayanand Thandalam Sriram Managing Director and Director
GlaxoSmithKline Consumer Nigeria Plc
--
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
$814.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUMITOMO DAINIPPON PHARMA CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.